en

PRODUCT DETAIL

Byooviz 10 mg/ml injekčný roztok

Code 8587D
MA number EU/1/21/1572/001
Product Form: sol inj 1x0,23 ml/2,3 mg (liek.inj.skl.+ ihla s filtr.+ihla inj.)
MA Status: E - Valid centralised marketing authorisation
Type of procedure: EU
Therapeutic Class: 64 - OPHTHALMOLOGICA
ATC:
S SENSORY ORGANS
S01 OPHTHALMOLOGICALS
S01L Ocular vascular disorder agents
S01LA Antineovascularisation agents
S01LA04 Ranibizumab
Shelf life: 48
Container: glass vial
Route of admin.: Intravitreal use
Prescription Status: Medicinal product subject to restricted medical prescription.
Legal basis: Article 10(4) similar biological application
MA issued: 18.08.2021
Validity: 18.08.2026
SmPC + PL: European Medicines Agency's database
Safety feature Yes
Data update: 22.01.2024
eu-flag.png sk-flag.png